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INTRODUCTION 
 Antibiotic resistance is a growing concern in 
clinical settings. As more pathogens acquire resistance to 
previously effective antibiotics, we face serious challenges 
controlling detrimental bacterial proliferation. The quest 
for novel and effective antibiotics has led scientists to re-
examine bacteria as a source of these compounds. In this 
work, we isolated a strain of Serratia that produces an 
extremely potent antimicrobial agent, effective against a 
broad range of pathogens. Using random transposon 
mutagenesis, we obtained mutants defective in antibiotic 
production. Several transposon insertions occurred in a 
large gene cluster predicted to encode enzymes involved in 
the synthesis of what appears to be a novel hybrid 
polyketide-non-ribosomal peptide (PK-NRP).  We are 
currently completing the sequence analysis of the gene 
cluster and determining the structure of the compound. 
 
METHODS, RESULTS & DISCUSSION  
 Isolates obtained from biofilms of a dairy 
processing plant were screened for production of 
antimicrobial. For that, the cell-free supernatant of 
stationary-phase cultures was tested on several Gram 
positive and negative pathogens. One of the many positive 
hits, a Serratia sp., was selected for more in-depth studies, 
due to the potency of the secreted compounds, that 
displayed antimicrobial activity against Helicobacter 
pylori, Campylobacter coli, Salmonella typhimurium, 
Staphylococcus aureus, Enterobacter sakazakii, Listeria 
monocytogenes, Bacillus cereus, Escherichia coli, 
Pseudomonas aeruginosa, among others. 
 To identify genes involved in the biosynthesis of 
the antimicrobial, transposon mutagenesis was carried out.  
Mutants were grown on minimal medium, over a layer of 
sterile membrane that allowed the diffusion of compounds 
while acting as a barrier to cells. After removal of the 
membrane, the cell-free, but exudate-rich, agar plates were 
overlaid with a lawn of Escherichia coli K12, to test for 
loss of halo (Figure 1).  
 Several random transposon mutants, which no 
longer displayed antimicrobial activity, were isolated. 
 
Figure 1: Screen for loss of antimicrobial production. Wild type (a) 
and transposon mutant (b) exudate, overlaid with E. coli K12.  Three 
replicates were grown per plate for the assay.  
 
 The genes that were interrupted by transposons 
were mapped by arbitrary PCR and the sequences obtained 
were used in a BLAST search against the non-redundant 
protein database. The initial sequences appeared to be 
encoding genes homologous to polyketide synthases 
(PKS) and non-ribosomal peptide synthases (NRPS).  
 PKS/NRPS gene clusters tend to be quite large, 
spanning tens of thousands of base pairs. To facilitate 
mapping of the entire biosynthetic region, we fully 
sequenced the genome of the Serratia sp. isolate. The 
regions upstream and downstream of the genes with 
transposon insertions were screened for open reading 
frames (ORF) using bioinformatic tools (DNASTAR 
Lasergene 8). The edges of the biosynthetic gene cluster 
were thus determined, based on predicted function (Figure 
2). Genes encoding proteins involved in the compound 
translocation are transcribed from both strands. However, 
the enzymes and other proteins predicted to be involved in 
the assembly of this molecule are transcribed from the plus 
strand.  
 
Figure 2: Map of the antimicrobial's biosynthetic gene cluster, of 
52.174 bp. The open reading frames and corresponding transcription 
direction are represented by arrows; the triangles represent locations of 
the transposon insertions that abolished antimicrobial production.  
  From the genome analysis it was possible to 
confirm that the antimicrobial compound being made is a 
PK-NRP hybrid.  PKS and NRPS genes are organized in 
clusters and result from the coordination and multistep 
activity of the enzymes arranged in these assembly lines. 
The core components include betaketoacyl synthases, 
which are responsible for polymerizing fatty acids - acyl-
CoA thioesters - into polyketides and amino acid 
adenylation domains are responsible for amino acid 
processing for incorporation in the compound (NRPS), as 
aminoacyl AMP anhydrides.   
 Simplifying, betaketoacyl synthases are 
responsible for polymerizing fatty acids - acyl-CoA 
thioesters - into polyketides. Amino acid adenylation 
domains are responsible for amino acid processing for 
incorporation in the compound (NRPS), as aminoacyl 
AMP anhydrides. 
 The type and order of the domains - the catalytic 
units of these enzymes - are directly responsible for when 
and which monomer is activated and added to the 
molecule, which transformation (post-translation 
modification) it will undergo, and the type and length of 
product that will eventually be made. Nevertheless, in the 
case of hybrid PK-NRP compounds as this, a full 
prediction of the outcome is particularly tricky, as it 
includes two distinct types of molecules. 
 The proteins predicted to be transcribed from the 
52.714 base pairs (bp) were characterized for their 
domains (Table 1), using several databases available 
online: ClusScan, Web-CD Search Tool, SMART, 
NRPSpredictor, NRPSpredictor2, PKS/NRPS Analysis 
Web-site and SBSPKS. The structure of this antimicrobial 
is currently being solved by Nuclear Magnetic Resonance, 
in collaboration with the Clardy Lab at Harvard Medical 
School (US).   
 
Table 1: Proteins predicted to be encoded by the biosynthetic gene 
cluster, and respective domains for post-translation modification. 
 
ORF Predicted Protein Domain 
1 
Pyridoxal-dependent 
decarboxylase 
Pyridoxal decarboxylase 
2 Hypothetical Protein No domains 
3 
Phosphopantetheinyl 
Transferase 
ACPS 
4 HlyD RND_mfp C 
5 ABC Transporter FtsE 
6 
Membrane Spanning 
Subunit 
FtsX 
7 Hypthetical Protein No domains 
8 Betaketoacyl Synthase 
KS; KS_C; AT; PP binding 
(PCP); KR; DH 
9 Betaketoacyl Synthase KS-KS_C; KS-KS_C; TE 
10 PfaD NPD_FabD; AAT_1 
11 3-Oxoacyl-Reductase ACP-Reductase 
12 Hypothetical Protein SDR_e1 
13 
NAD(P)binding 
Protein 
Nitrilase 
14 
aa Adenylation 
Domain 
A (?); PCP; C; A (Phe); 
PCP/T; C; A (Asn); PCP; C/E: 
C/Cy; A (Asn); PCP/T 
15 
aa Adenylation 
Domain 
C/E; A (Thr/dht); PCP; C; A 
(Val); PCP 
16 
6-Deoxyerythronolide-
B-Synthase 
KS-KS_C; AT; KR/E; ACP 
17 
Condensation-
Domain-Containing 
Protein 
C; E/Cy 
18 
Polyamine-
Transporting ATPase 
P-Loop NTPase; 
Methyltransferase 
19 
ABC-2-type 
Transporter 
ABC-type multidrug transport 
system, permease component 
20 
Hydrolase family 
protein 
Esterase 
 
A(aa) =Adenylation (amino acid activated); ACPS=holo-[acyl-carrier-
protein] synthase; RND_mfp C=Resistance-Nodulation-Cell 
Division_Membrane Fusion Protein; FtsE=Cell Division ATP-binding 
protein; FtsX=protein insertion permease; KS=ketosynthase; KS_C=C-
terminus; AT=aminotransferase; PP_binding= Phosphopantetheine 
attachment site; KR=ketoreductase; DH=dehydrogenase; 
TE=thioesterase; ACP=Acyl Carrier Protein; NPD=Nitropropane 
dioxygenase; AAT_1=Aspartate Aminotransferase; SDR_e1=Short-chain 
dehydrogenases/reductases; PCP=Peptidyl Carrier Protein; 
C=Condensation; Cy=Cyclization; E=Epimerization; T=Thiolation. 
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